Davide Fiore Bavaro Selected Research

Davide Fiore Bavaro Research Topics

9	Infections 03/2022 - 01/2021
4	COVID-19 05/2021 - 01/2020
2	Tuberculosis (Tuberculoses) 03/2022 - 11/2021
2	Sepsis (Septicemia) 03/2022 - 08/2021
2	Fibrosis (Cirrhosis) 11/2021 - 01/2019
2	Pneumonia (Pneumonitis) 05/2021 - 03/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2022
1	Communicable Diseases (Infectious Diseases) 03/2022
1	Candidemia 03/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	HIV Infections (HIV Infection) 01/2022
1	Penetrating Atherosclerotic Ulcer 01/2022
1	Non-alcoholic Fatty Liver Disease 11/2021
1	Renal Insufficiency (Renal Failure) 11/2021
1	Kidney Diseases (Kidney Disease) 11/2021
1	Endocarditis 08/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021
1	Lung Neoplasms (Lung Cancer) 06/2021
1	Hematologic Neoplasms (Hematological Malignancy) 05/2021
1	Critical Illness (Critically Ill) 05/2021
1	Gram-Positive Bacterial Infections 05/2021
1	Disease Progression 05/2021
1	Intraabdominal Infections 03/2021
1	Urinary Tract Infections (Urinary Tract Infection) 03/2021
1	Pulmonary Embolism 01/2021
1	Opportunistic Infections (Opportunistic Infection) 07/2020
1	Multiple Sclerosis 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Liver Diseases (Liver Disease) 01/2019

3	ceftazidime drug combination avibactamIBA 03/2022 - 05/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2021
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 05/2021
2	CefiderocolIBA 05/2021 - 03/2021
1	Vitamin D FDA LinkGeneric 03/2022
1	carbapenemaseIBA 03/2022
1	meropenem and vaborbactamIBA 03/2022
1	Aztreonam FDA LinkGeneric 03/2022
1	Fluconazole (Zonal)FDA LinkGeneric 03/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	avibactamIBA 01/2022
1	VitaminsIBA 11/2021
1	MicronutrientsIBA 11/2021
1	ZincIBA 11/2021
1	Vitamin A (Retinol)FDA LinkGeneric 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	Daptomycin FDA Link 08/2021
1	Vancomycin FDA LinkGeneric 08/2021
1	NivolumabIBA 06/2021
1	Immune Checkpoint InhibitorsIBA 06/2021
1	pembrolizumabIBA 06/2021
1	dalbavancinIBA 05/2021
1	SiderophoresIBA 03/2021
1	Cephalosporins (Cephalosporin Antibiotics)IBA 03/2021
1	Pharmaceutical PreparationsIBA 03/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 01/2021
1	VaccinesIBA 01/2021
1	teriflunomideIBA 01/2020
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2020
1	Viral RNAIBA 01/2019
1	HLA-B18 AntigenIBA 01/2019

6	Therapeutics 03/2022 - 07/2020
3	Length of Stay 05/2022 - 05/2021
1	Chest Tubes (Chest Tube) 05/2022
1	Glycemic Control 11/2021
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 11/2021
1	Immunotherapy 06/2021
1	Organ Transplantation 05/2021
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2021